RJ

Rajnish Jain

Active Director Director DIN 08702609
DIN 08702609 First appointment Feb 2020 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Feb 2020
Shareholding value •••• Premium profile

About Rajnish Jain

Data last updated:

Rajnish Jain is a Director at Resurgence Healthcare India Private Limited (since 2020). The company operates in Pharma. Resurgence Healthcare India Private Limited reported revenue of ₹1.12 Cr (FY 2025).

DIN 08702609
Primary Designation Director
Industry Pharma
First Appointment 18 Feb 2020
Oldest Company Age 6 yrs
Largest company Resurgence Healthcare India Private Limited · ₹1.12 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director18 Feb 20202020₹1.12 Cr (FY 2025)Active

Board colleagues of Rajnish Jain

Directorship timeline

Open interactive timeline →
Resurgence Healthcare India Private Limited
Premium access

Shareholding and investment profile for Rajnish Jain

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Rajnish Jain

Rajnish Jain currently holds 1 directorship: Resurgence Healthcare India Private Limited (Director, since 18 Feb 2020, revenue ₹1.12 Cr (FY 2025)).

Rajnish Jain was first appointed on 18 Feb 2020 as Director at Resurgence Healthcare India Private Limited.

The current boards of Rajnish Jain's companies include Ashwani Jain (Resurgence Healthcare India Private Limited), Love Jain (Resurgence Healthcare India Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available